USAM yields 20000.00% · JNJ yields 2.13%● Live data
📍 USAM pulled ahead of the other in Year 1
Combined, USAM + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of USAM + JNJ for your $10,000?
U.S. Automotive Manufacturing, Inc. manufactures new and rebuilt automotive friction products. The company's line of friction automotive products include brake lining, integrally molded and riveted brake pads, and remanufactured brake shoes. Brake pads, brake shoes or a combination of both are incorporated in all makes and models of American and imported automobiles. It markets various grades of friction lining, asbestos, non-asbestos organic, and semi-metallic formulas, suitable for use by the automotive and light truck after-markets. It generally produces the replacement brakes under the same process used to manufacture the vehicle's original equipment. The company sells its products to wholesale and retail automotive distributors, mass merchandisers, chain stores, and to other brake manufacturers in the United States and in 11 foreign countries. U.S. Automotive Manufacturing, Inc. was founded in 1992 and is based in Sanford, Florida.
Full USAM Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.